Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

NCT01954121 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
436
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma SA